[go: up one dir, main page]

DK1192152T3 - Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse - Google Patents

Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse

Info

Publication number
DK1192152T3
DK1192152T3 DK00949575T DK00949575T DK1192152T3 DK 1192152 T3 DK1192152 T3 DK 1192152T3 DK 00949575 T DK00949575 T DK 00949575T DK 00949575 T DK00949575 T DK 00949575T DK 1192152 T3 DK1192152 T3 DK 1192152T3
Authority
DK
Denmark
Prior art keywords
preparation
fluorinated
derivatives
benzodioxanimidazoline
therapeutic use
Prior art date
Application number
DK00949575T
Other languages
English (en)
Inventor
Thierry Imbert
Patrice Mayer
Marc Marien
Peters Pauwels
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK1192152T3 publication Critical patent/DK1192152T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00949575T 1999-06-29 2000-06-29 Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse DK1192152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908302A FR2795727B1 (fr) 1999-06-29 1999-06-29 Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
PCT/FR2000/001825 WO2001000619A1 (fr) 1999-06-29 2000-06-29 Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique

Publications (1)

Publication Number Publication Date
DK1192152T3 true DK1192152T3 (da) 2003-03-17

Family

ID=9547432

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00949575T DK1192152T3 (da) 1999-06-29 2000-06-29 Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse

Country Status (16)

Country Link
US (1) US6610725B1 (da)
EP (1) EP1192152B1 (da)
JP (1) JP4608160B2 (da)
CN (1) CN1139588C (da)
AT (1) ATE228516T1 (da)
AU (1) AU778796B2 (da)
BR (1) BR0012042A (da)
CA (1) CA2377186A1 (da)
DE (1) DE60000880T2 (da)
DK (1) DK1192152T3 (da)
ES (1) ES2186654T3 (da)
FR (1) FR2795727B1 (da)
MX (1) MXPA02000256A (da)
PT (1) PT1192152E (da)
WO (1) WO2001000619A1 (da)
ZA (1) ZA200200009B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
US20110165037A1 (en) * 2010-01-07 2011-07-07 Ismagilov Rustem F Interfaces that eliminate non-specific adsorption, and introduce specific interactions
KR20190020343A (ko) * 2016-06-29 2019-02-28 오리온 코포레이션 벤조디옥산 유도체 및 이의 약제학적 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions

Also Published As

Publication number Publication date
FR2795727A1 (fr) 2001-01-05
JP2003503406A (ja) 2003-01-28
CN1361776A (zh) 2002-07-31
EP1192152B1 (fr) 2002-11-27
MXPA02000256A (es) 2002-06-21
DE60000880T2 (de) 2003-08-28
EP1192152A1 (fr) 2002-04-03
DE60000880D1 (de) 2003-01-09
ES2186654T3 (es) 2003-05-16
ZA200200009B (en) 2002-09-25
WO2001000619A1 (fr) 2001-01-04
CN1139588C (zh) 2004-02-25
FR2795727B1 (fr) 2001-09-21
AU778796B2 (en) 2004-12-23
AU6289000A (en) 2001-01-31
CA2377186A1 (fr) 2001-01-04
PT1192152E (pt) 2003-04-30
US6610725B1 (en) 2003-08-26
BR0012042A (pt) 2002-07-09
ATE228516T1 (de) 2002-12-15
JP4608160B2 (ja) 2011-01-05

Similar Documents

Publication Publication Date Title
SE0104334D0 (sv) Therapeutic agents
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
EA200201141A1 (ru) Производные тропана, полезные для терапии
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
DK1192152T3 (da) Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse
ES8606337A1 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
DK0484378T3 (da) Antiarytmiske tertiær amin-alkenyl-phenyl-alkansulfonamider
IL98454A0 (en) Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes,their preparation and their therapeutic application
ES2062792T3 (es) Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos.
ATE122683T1 (de) Epoxybernsteinsäurederivate, verwendbar als spezifische hemmer von cathepsin b.
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
DK0520882T3 (da) Derivater af 2-aminopyrimidin-4-carboxamid, deres fremstilling og deres terapeutiske anvendelse
ES2031594T3 (es) Tioeteres aromaticos.
DK0707587T3 (da) Farmakologisk aktive enantiomerer
PT86852A (pt) Procede de preparation des nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2
DE60239324D1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TH31626A (th) สารประกอบใหม่ที่ให้ผลในการระงับปวด